Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (2725)	10/10/2006 10:13:40 AM
From: tuck	Read Replies (2) of 3044

>>9:50AM Anormed: Genzyme announces proposal to increase its offer to acquire AnorMED to $13.50 per share in cash (ANOR) 13.35 : Genzyme (GENZ) announces that it has informed the Board of Directors of ANOR that it is prepared to increase its offer to acquire all outstanding shares of ANOR to US $13.50 per share, or approximately $580 mln, contingent upon ANOR executing a support agreement with GENZ. GENZ says this proposal represents a premium of 12.5% over the purchase price proposed by Millennium Pharmaceuticals (MLNM) on September 26, 2006. (ANOR IS halted)<< From Briefing.com It appears MLNM is halted, too. Edit: Found the right 14-D9 or sumthin at EDGAR, from which this is excerpted: "The Support Agreement provides for the payment to Millennium by AnorMED, upon the occurrence of certain events, including the acceptance by the Board of Directors of a superior proposal that Millennium has not matched, of a fee of U.S.$19.5 million." Hey, we'll take a quick $20 million, sure. MLNM appears to be trading again, and oddly, isn't moving much. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next